1 – 50 of 50
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Esophagus Dilation and Quality of Life in Adults with Scleroderma and Concomitant Obstructive Sleep Apnea
(
- Contribution to journal › Article
- 2023
-
Mark
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Systemic sclerosis and primary biliary cholangitis : Longitudinal data to determine the outcomes
(
- Contribution to journal › Article
-
Mark
Gastrointestinal tract involvement in systemic sclerosis : The roles of diet and the microbiome
(
- Contribution to journal › Article
- 2022
-
Mark
N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis : A systematic literature review focusing on validation and standardization – WSF Skin Ultrasound Group
(
- Contribution to journal › Scientific review
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
(
- Contribution to journal › Article
- 2021
-
Mark
Cardiac Microvascular Disease Quantified with CMR
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
(
- Contribution to journal › Article
-
Mark
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis globally : A comprehensive systematic review and meta-analysis
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis
(
- Contribution to journal › Article
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
(
- Contribution to journal › Article
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
(
- Contribution to journal › Article
- 2019
-
Mark
Exocrine pancreatic function is preserved in systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL) : A novel measure of quality of life for patients with systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
(
- Contribution to journal › Article
-
Mark
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe : Results From the ERA-EDTA Registry
(
- Contribution to journal › Article
- 2018
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article
-
Mark
Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis : A magnetic resonance study
(
- Contribution to journal › Article
- 2017
-
Mark
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease : A multicentre European Scleroderma Trials and Research group (EUSTAR) study
(
- Contribution to journal › Article
-
Mark
Systemic sclerosis
2017) p.165-178(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
-
Mark
Quantitative outcome measures for systemic sclerosis-related Microangiopathy – Reliability of image acquisition in Nailfold Capillaroscopy
(
- Contribution to journal › Article
-
Mark
Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis : Analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening
(
- Contribution to journal › Article
-
Mark
Mapping and predicting mortality from systemic sclerosis
(
- Contribution to journal › Article
-
Mark
ESVM guidelines – the diagnosis and management of raynaud’s phenomenon
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Brief Report : IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
(
- Contribution to journal › Article
-
Mark
The modified hand mobility in scleroderma test and skin involvement - A followup study
(
- Contribution to journal › Article
-
Mark
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Telocytes, communicators in healthy stroma and relation to inflammation and fibrosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease
(
- Contribution to journal › Article
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
- 2015
-
Mark
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
(
- Contribution to journal › Article
- 2013
-
Mark
Systemic sclerosis. Novel molecular and epidemiological features of disease.
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods
(
- Contribution to journal › Article
-
Mark
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis
(
- Contribution to journal › Article
- 2007
-
Mark
BAL fluid derived fibroblasts differ from biopsy derived fibroblasts in systemic sclerosis.
(
- Contribution to journal › Article
-
Mark
Wound healing after hand surgery in patients with systemic sclerosis-a retrospective analysis of 41 operations in 19 patients.
(
- Contribution to journal › Article
- 2005
-
Mark
Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001.
(
- Contribution to journal › Article
- 2004
-
Mark
Hand function, Everyday Occupations and Wellbeing in Individuals with Systemic Sclerosis
2004)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
Skin fibrosis, internal organ involvement and auto antibodies in systemic sclerosis: longitudinal development and impact on survival
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis
(
- Contribution to journal › Article
- 2001
-
Mark
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
(
- Contribution to journal › Article